Bortezomib treatment for patients with mantle-cell lymphoma

被引：3
|
作者：
Tanday, Sanjay
机构：
来源：
LANCET ONCOLOGY | 2015年 / 16卷 / 04期
关键词：
D O I：
10.1016/S1470-2045(15)70117-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E162 / E162
页数：1
相关论文
共 50 条
  • [31] CNS involvement in Mantle-cell lymphoma
    Montserrat, E
    Bosch, F
    LopezGuillermo, A
    Graus, F
    Terol, MJ
    Campo, E
    Rozman, C
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 941 - 944
  • [32] An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma
    Morabito, Fortunato
    Recchia, Anna Grazia
    Vigna, Ernesto
    Botta, Cirino
    Skafi, Mamdouh
    Abu-Rayyan, Mohammed
    Atrash, Moien
    Galimberti, Sara
    Morabito, Lucio
    Al-Janazreh, Hamdi
    Martino, Massimo
    Cutrona, Giovanna
    Gentile, Massimo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (01) : 29 - 38
  • [33] Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma
    Ruan, Jia
    Martin, Peter
    Shah, Bijal
    Schuster, Stephen J.
    Smith, Sonali M.
    Furman, Richard R.
    Christos, Paul
    Rodriguez, Amelyn
    Svoboda, Jakub
    Lewis, Jessica
    Katz, Orel
    Coleman, Morton
    Leonard, John P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19): : 1835 - 1844
  • [34] Maintenance rituximab in mantle-cell lymphoma
    Burki, Talha Khan
    LANCET ONCOLOGY, 2017, 18 (11): : E647 - E647
  • [35] Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network
    Hoster, Eva
    Klapper, Wolfram
    Hermine, Olivier
    Kluin-Nelemans, Hanneke C.
    Walewski, Jan
    van Hoof, Achiel
    Trneny, Marek
    Geisler, Christian H.
    Di Raimondo, Francesco
    Szymczyk, Michal
    Stilgenbauer, Stephan
    Thieblemont, Catherine
    Hallek, Michael
    Forstpointner, Roswitha
    Pott, Christiane
    Ribrag, Vincent
    Doorduijn, Jeanette
    Hiddemann, Wolfgang
    Dreyling, Martin H.
    Unterhalt, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (13) : 1338 - 1346
  • [36] Composite mantle-cell lymphoma and plasmacytoma
    Cachia, AR
    Diss, TC
    Isaacson, PG
    HUMAN PATHOLOGY, 1997, 28 (11) : 1291 - 1295
  • [37] ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO
    Carlos, F.
    Herrera, M.
    Salazar, A.
    Aguirre, A.
    Gonzalez-Michaca, L.
    VALUE IN HEALTH, 2016, 19 (03) : A249 - A249
  • [38] Bortezomib in mantle cell lymphoma
    Sub, K. Stephen
    Goy, Andre
    FUTURE ONCOLOGY, 2008, 4 (02) : 149 - 168
  • [39] Composite mantle-cell lymphoma and classical Hodgkin lymphoma
    Hayes, SJ
    Banerjee, SS
    Cook, Y
    Houghton, JB
    Menasce, LP
    HISTOPATHOLOGY, 2006, 48 (05) : 621 - 623
  • [40] Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma
    Jin, Jie
    Okamoto, Rumiko
    Yoon, Sung-Soo
    Shih, Lee-Yung
    Zhu, Jun
    Liu, Ting
    Hong, Xiaonan
    Pei, Lixia
    Rooney, Brendan
    van de Velde, Helgi
    Huang, Huiqiang
    ONCOTARGETS AND THERAPY, 2018, 11 : 3869 - 3882
12345